非化疗药物诱导亚核细胞分裂:基于FAERS数据库的不成比例性分析
Shanshan Wu1, Lina Huang1, Jiajia Chen1
1Department of Clinical Pharmacy, Jieyang People's Hospital, Jieyang, China.
Frontiers in pharmacology
|March 20, 2025
概括
这项研究确定了166种非化疗药物与农细胞结核病相关,包括新的潜在风险. 死亡率下降,但在女性,儿童和老年人中观察到更早的发病,这凸显了针对性监测的必要性.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学 临床药理学
背景情况:
- 非化疗药物诱导的亚核细胞症 (NCDIA) 是一种严重的不良反应,增加了感染风险.
- 现有关于NCDIA的文档缺乏从大规模药监数据中进行全面分析.
研究的目的:
- 使用FAERS数据库报告系统地识别和描述NCDIA.
- 检测新型非化疗药物与农细胞瘤相关.
- 分析NCDIA的发病模式和死亡率趋势.
主要方法:
- 来自FAERS数据库的NCDIA报告 (2004-2024 Q1) 的回顾性分析.
- 使用解剖治疗化学 (ATC) 系统对药物进行分类,不包括化疗剂.
- 报告几率比率 (ROR) 信号检测方法;通过>=3个报告定义的正信号和ROR 95% CI > 1.
- 对人口统计和药物特定发病模式的时间到事件分析.
主要成果:
- 确定了10,913份NCDIA报告,其中166种非化疗药物有显著信号.
- 将药物分类为已知的 (111),可能的 (25) 和新的潜在风险 (30).
- 在女性,儿童和老年人中观察到较早的农细胞瘤发病.
- 发现与NCDIA相关的死亡率从11.91% (2004-2010) 显著下降到7.28% (2021-2024).
结论:
- 确认已知的NCDIA关联,并确定了新的潜在风险药物.
- 新的风险分类和发病时间分析为临床监测提供了洞察力.
- 这些发现支持针对性的监测策略,并改善了NCDIA的患者安全.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.1K
相关概念视频
01:19Pharmacovigilance
762
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
762
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K